|
(ÁÖ)ÄھƽºÆ®·Ð |
ÀÇ·á±â±â A/S ¿£Áö´Ï¾î ¸ðÁý
¼¿ï °³²±¸ | °íµîÇб³ |
AS/Á¤ºñ/¼ö¸®/¼³Ä¡ |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.14 |
|
|
(ÁÖ)¼±¸í¾àÇ° |
ÀǾàÇ°¿µ¾÷´ã´çÀÚ°æ·Â¹×½ÅÀÔ»ç¿ø¸ðÁý
Àü±¹ ÀüÁö¿ª | °íµîÇб³ |
¿µ¾÷°ü¸®/¿µ¾÷Áö¿ø |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.05 |
|
|
¸Þµð¿þÀÌ |
¸Þµð¿þÀÌ º´¿øÀü¿ë ÈÀåÇ° ¹× ÀÇ·á±â±â¿µ¾÷
¼¿ï ¼ºµ¿±¸ | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
04.23 |
|
|
ICON Clinical Research Korea |
Study Start-up Associate
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
ICON Clinical Research Korea |
Jr. Clinical Research Associate(Oncology)
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
04.22 |
|
|
¸Þµð¾Û¼Ö |
ÀÇ·á¼Ò¸ðÇ° ´ëÇк´¿ø ¹× Á¾ÇÕº´¿ø ¿µ¾÷
¼¿ï ¼´ë¹®±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿µ¾÷°ü¸®/¿µ¾÷Áö¿ø |
½ÅÀÔ |
»ó½Ãä¿ë |
03.20 |
|
|
(ÁÖ) ³×¿À ¿þÀ̺ê |
ÀÇ·á±â±â(¹Ì¿ëÀåºñ) ÆǸŠ»ç¿ø ¸ðÁý
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.20 |
|
|
(ÁÖ)ĸ޵ð |
ÀÇ·á±â±â ¿µ¾÷»ç¿ø ¸ðÁýÇÕ´Ï´Ù.
¼¿ï ±¸·Î±¸, °æ±â ¼º³²½Ã ºÐ´ç±¸ | Çз¹«°ü |
¿µ¾÷°ü¸®/¿µ¾÷Áö¿ø |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.18 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Dedicated CRA / CRA ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Clinical Lead (for Dedicated CRA) ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
ÀδٶóÇÑÀÇ¿ø |
ÇѾà»ç¸ðÁý
¼¿ï ±¤Áø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.12 |
|
|
(ÁÖ)³×¿À¹ÙÀÌ¿À |
(ÁÖ)³×¿À¹ÙÀÌ¿À °Ç°½ÄÇ° ¿µ¾÷ ±âȹ
¼¿ï ¼ºµ¿±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
06.29 |
|
|
B. Braun Korea |
2012³â ºñºê¶ó¿îÄÚ¸®¾Æ ½ÅÀÔ»ç¿ø ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°ø°³Ã¤¿ë |
½ÅÀÔ |
ä¿ë½Ã |
06.08 |
|
|
±âºìÁ¸¸ÞµðÄ®(A&MT) |
¿µ¾÷»ç¿ø ¸ðÁý
¼¿ï ÀüÁö¿ª | °íµîÇб³ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.04 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ CRA ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
05.16 |
|